Federal contract award
75D30122C15503
EVALUATION OF EMERGING INFECTIONS DURING PREGNANCY AND THEIR PREVENTION AND
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541713 — Research and Development in Nanotechnology |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $748.6K |
| Current contract value | $748.6K |
| Potential contract value / ceiling | $748.6K |
| Start date | Sep 30, 2022 |
| Current end date | Mar 28, 2025 |
| Potential end date | Mar 28, 2025 |
| Latest award activity | Sep 10, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2024 | P00002 | $0 | EVALUATION OF EMERGING INFECTIONS DURING PREGNANCY AND THEIR PREVENTION AND TREATMENT USING ENHANCED AND DIVERSE MOTHER-BABY COHORTS |
| Oct 18, 2022 | P00001 | $0 | EVALUATION OF EMERGING INFECTIONS DURING PREGNANCY AND THEIR PREVENTION AND |
| Sep 22, 2022 | 0 | $748.6K | EVALUATION OF EMERGING INFECTIONS DURING PREGNANCY AND THEIR PREVENTION AND |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.